Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
EBITDA margin, % ? 36.6% -14.8% -0.03% -38.8% -29.2%   -31.5%  
Changes by years, y/y, % +47pp -51pp +15pp -39pp +10pp     +23.3%

Ionis Pharmaceuticals. EBITDA margin, %

Ionis Pharmaceuticals. EBITDA margin, changes, pp

Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA margin, % ? -78.6% 7.76% -96.2% -16.8% -93.4%   -31.5%
Changes by years, y/y, % -47pp +243pp -22pp +15pp -15pp    
Changes by quarters, q/q, % -47pp +86pp -104pp +79pp -77pp    

Ionis Pharmaceuticals. EBITDA margin, %

Ionis Pharmaceuticals. EBITDA margin, changes, pp

Ionis Pharmaceuticals. EBITDA margin, changes, pp